JPS5927813A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPS5927813A
JPS5927813A JP58124582A JP12458283A JPS5927813A JP S5927813 A JPS5927813 A JP S5927813A JP 58124582 A JP58124582 A JP 58124582A JP 12458283 A JP12458283 A JP 12458283A JP S5927813 A JPS5927813 A JP S5927813A
Authority
JP
Japan
Prior art keywords
indapamide
hydroxypropoxy
tert
compounds
thiachroman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58124582A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0250084B2 (fr
Inventor
ラブイリ−・エテイアンヌ
モル・ダニエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of JPS5927813A publication Critical patent/JPS5927813A/ja
Publication of JPH0250084B2 publication Critical patent/JPH0250084B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58124582A 1982-07-09 1983-07-08 医薬組成物 Granted JPS5927813A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8212058 1982-07-09
FR8212058A FR2529785A1 (fr) 1982-07-09 1982-07-09 Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne

Publications (2)

Publication Number Publication Date
JPS5927813A true JPS5927813A (ja) 1984-02-14
JPH0250084B2 JPH0250084B2 (fr) 1990-11-01

Family

ID=9275835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58124582A Granted JPS5927813A (ja) 1982-07-09 1983-07-08 医薬組成物

Country Status (16)

Country Link
JP (1) JPS5927813A (fr)
AU (1) AU557601B2 (fr)
BE (1) BE897251A (fr)
CA (1) CA1197191A (fr)
CH (1) CH655007A5 (fr)
DE (1) DE3324785C2 (fr)
FR (1) FR2529785A1 (fr)
GB (1) GB2123293B (fr)
IE (1) IE55364B1 (fr)
IT (1) IT1173729B (fr)
LU (1) LU84902A1 (fr)
NL (1) NL8302435A (fr)
NZ (1) NZ204849A (fr)
OA (1) OA07489A (fr)
SE (1) SE8303886L (fr)
ZA (1) ZA834978B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
PL193976B1 (pl) 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092004A1 (fr) * 1970-04-06 1972-01-21 Science Union & Cie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203691A (en) * 1968-03-06 1970-09-03 Science Union & Cie New disubstituted n-amino indoline derivatives and process for preparing them
IL39625A0 (en) * 1971-06-15 1972-11-28 Ciba Geigy Ag New pharmaceutical preparations for the treatment of hypertonia,containing a diuretic and a beta-receptor blocking agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092004A1 (fr) * 1970-04-06 1972-01-21 Science Union & Cie

Also Published As

Publication number Publication date
GB2123293B (en) 1985-10-09
JPH0250084B2 (fr) 1990-11-01
NL8302435A (nl) 1984-02-01
GB2123293A (en) 1984-02-01
CH655007A5 (fr) 1986-03-27
NZ204849A (en) 1986-04-11
FR2529785B1 (fr) 1984-12-07
OA07489A (fr) 1985-03-31
CA1197191A (fr) 1985-11-26
SE8303886D0 (sv) 1983-07-07
GB8318512D0 (en) 1983-08-10
IE55364B1 (en) 1990-08-29
BE897251A (fr) 1984-01-09
AU1670283A (en) 1984-01-12
AU557601B2 (en) 1986-12-24
DE3324785C2 (de) 1986-10-09
IE831597L (en) 1984-01-09
IT8348641A0 (it) 1983-07-07
SE8303886L (sv) 1984-01-10
DE3324785A1 (de) 1984-01-12
FR2529785A1 (fr) 1984-01-13
IT1173729B (it) 1987-06-24
ZA834978B (en) 1984-03-28
LU84902A1 (fr) 1984-03-22

Similar Documents

Publication Publication Date Title
Ho et al. Cyclic adenosine monophosphate antagonism of morphine analgesia
CA2232008C (fr) Utilisation d'epinastine pour traiter la douleur
Cohen Risperidone
Byfield et al. Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents
PT99690B (pt) Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina
Aparici et al. Pharmacological profile of AZD8871 (LAS191351), a novel inhaled dual M3 receptor antagonist/β2-adrenoceptor agonist molecule with long-lasting effects and favorable safety profile
CZ289395A3 (en) Transdermic therapeutic system for administration of serotonin agonists
Jones et al. The effect of cyproheptadine on the release of corticotrophin releasing factor
Heaslip et al. Phosphodiesterase-IV inhibition, respiratory muscle relaxation and bronchodilation by WAY-PDA-641.
JPH08500018A (ja) プロテインキナーゼｃ（イオタ）
Szabo et al. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
JPH0250084B2 (fr)
US4851408A (en) Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazol[5,4-d]azepine for releasing growth hormone
Leysen et al. Ketanserin reduces a particular monoamine pool in peripheral tissues.
EP0132880A1 (fr) Compositions pharmaceutiques à base d'épinine ou un sel pharmaceutiquement acceptable
Speth et al. Rat (Ile5) but not bovine (Val5) angiotensin raises plasma norepinephrine in rats.
Saxena Further characterization of 5‐hydroxytryptamine1‐like receptors mediating tachycardia in the cat: No apparent relationship to known subtypes of the 5‐hydroxytryptamine1 binding site
Ruffolo, Jr et al. Alpha-2-adrenoceptor-mediated effects of pergolide
WO2002083137A1 (fr) Utilisation d'antagonistes du recepteur de npy y¿2?
Williams Jr et al. Inhibitory modulation by cAMP of isoproterenol-induced prostacyclin synthesis in rabbit heart
Horiuchi et al. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
Nies et al. Recent concepts in the clinical pharmacology of anithypertensive drugs
Cohen et al. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR
JPS59500718A (ja) 静細胞作用を有する医薬組成物
Kim et al. Bradycardia induced by mivazerol, a selective α2-Adrenoceptor agonist, is amplified during mild hypothermia in the pentobarbital-anesthetized rat